𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide

✍ Scribed by E. Keller; G. Hoppe-Seyler; R. Mumm; P. Schollmeyer

Publisher
Springer
Year
1981
Tongue
English
Weight
582 KB
Volume
20
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The influence of hepatic cirrhosis on th
The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride
✍ Dr G. Kaiser; R. Ackermann; H. P. Gschwind; I. M. James; D. Sprengers; N. McInty πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 552 KB

The influence of hepatic disease on the pharmacokinetics of the new ACE inhibitor, benazepril hydrochloride, was evaluated in 12 male patients suffering from liver cirrhosis. The patients received a single oral 20 mg dose. The plasma concentrations and urinary excretion of unchanged benazepril and i

Renal failure in the ICU: Comparison of
Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes
✍ Clermont, Gilles; Acker, Christopher G.; Angus, Derek C.; Sirio, Carl A.; Pinsky πŸ“‚ Article πŸ“… 2002 πŸ› Nature Publishing Group 🌐 English βš– 609 KB

## Background: Acute renal failure (arf) is associated with a persistent high mortality in critically ill patients in intensive care units (icus). most studies to date have focused on patients with established, intrinsic arf or relatively severe arf due to multiple factors. none have examined outco